and as a final but crucially important point, i agree with...

and as a final but crucially important point, i agree with previous posters that the current market cap of 48mill aud seems incredibly undervalued given:
1) net cash position
2) positive cashflows
3) looming 50m+ lifescan windfall
4) xprecia growth trajectory long term
5) ip value
6) plant and asset value

surely the market cap deserves to be at least 60mill+.

if i was the cfo/ ceo of the new owner of lifescan, i would certainly be thinking that it makes more sense to buy ubi outright for 35-40c / share at 60-70mill than to pay the option fee of around 50mill. i have no doubt that they will consider the idea. the formal sale wont happen until h2 2018 so i guess we will have to wait and see.